Alto Neuroscience Inc. (ANRO)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 68
- Market Cap
- $1.1B
About Alto Neuroscience Inc.
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
SentiSense also tracks daily options readings for Alto Neuroscience Inc.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Alto Neuroscience Inc. stock analysis, sentiment tracking, and market intelligence on SentiSense.